SCHEMBL3344675

SCHEMBL3344675

CCc1cccc(O)c1-c1c(O)cccc1CC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.61
GABRB2 P47870 2/20 0.61
ANPEP P15144 1/20 0.53
DPP4 P27487 1/20 0.53
IAPP P10997 3/20 0.46
MAOA P21397 2/20 0.44
HSPA5 P11021 1/20 0.44
CA12 O43570 2/20 0.43
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA7 P43166 2/20 0.43
CA9 Q16790 2/20 0.43
CA14 Q9ULX7 2/20 0.43
DAO P14920 2/20 0.43
DDO Q99489 1/20 0.43
ALDH1A1 P00352 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11019413 0.98 GABRA1 (0.58) GABRA1GABRB2ANPEPDPP4IAPP
SCHEMBL11018106 0.85 ANPEP (0.54) GABRA1GABRB2ANPEPDPP4MAOA
SCHEMBL980893 0.85 GABRA1 (0.50) GABRA1GABRB2ANPEPDPP4HSPA5
SCHEMBL10965181 0.85 ANPEP (0.54) GABRA1GABRB2ANPEPDPP4MAOA
SCHEMBL27728745 0.83 ANPEP (0.53) GABRA1GABRB2ANPEPDPP4MAOA
Potassium SCHEMBL324000 0.83 GABRA1 (0.48) GABRA1GABRB2ANPEPDPP4HSPA5
Ammonia Solution, Strong SCHEMBL324962 0.83 GABRA1 (0.48) GABRA1GABRB2ANPEPDPP4HSPA5
SCHEMBL5691479 0.83 GABRA1 (0.48) GABRA1GABRB2ANPEPDPP4IAPP
SCHEMBL11017672 0.82 GABRA1 (0.52) GABRA1GABRB2ANPEPDPP4IAPP
SCHEMBL3829265 0.81 ELANE (0.51) GABRA1GABRB2ANPEPDPP4IAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9315435-B2 Method for producing hydroxyphenylcyclohexanol compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-04-19 US disclosed
US-20150141707-A1 METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-05-21 US disclosed
EP-2842930-A1 METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND Sumitomo Chemical Company Limited (JP) 2015-03-04 EP disclosed
WO-2010042313-A1 SLURRY PROCESS FOR SYNTHESIS OF BISPHOSPHITES DOW TECHNOLOGY INVESTMENTS LLC (US) 2010-04-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150141707-A1 METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND HSD11B2, CYP21A2, CYP11B2 GABRA1 1252/4885GABRB2 835/4885ANPEP 4051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.